the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
November 08, 2018 – The American Food and Drug Administration (FDA) has just authorized the first direct-to-consumer test for detecting genetic variants in genes that may govern the metabolism of drugs in individual patients. Thus, FDA permits marketing, with special controls, the …
February 22, 2015 – The U.S. Food and Drug Administration authorized for marketing 23andMe’s Bloom Syndrome carrier test, a direct-to-consumer (DTC) genetic test to determine whether a healthy person has a variant in the BLM gene that could lead to their offspring inheriting the serious …
Bloom Syndrome: FDA permits marketing of first direct-to-consumer genetic carrier test Read more »